S Gong1, Z Seng1, W Wang2, J Lv1, Q Dong1, B Yan3, L Peng4, X He5. 1. Department of Neurosurgery, The Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Shaanxi Province, China. 2. Department of Spine Surgery, Xi'an Red Cross Society Hospital, Xi'an Jiaotong University, Shaanxi Province, China. 3. Department of Emergency Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Shaanxi Province, China. 4. Department of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Shaanxi Province, China. 5. Department of Orthopaedics, The Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Shaanxi Province, China.
Abstract
STUDY DESIGN: Experimental study. OBJECTIVES: To investigate whether Bosentan, an endothelin-A/-B dual receptor antagonist, could protect neurons after spinal cord ischemia reperfusion (SCIR) injury in rats and its underlying signaling pathway. SETTING: Department of Neurosurgery, the Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi Province, China. METHODS: Sprague-Dawley rats were randomly divided into two groups, saline group (IRS, n=48) and Bosentan group (IRB, 5 mg kg(-1), n=48). After ischemia for 1 h with occlusion of the infrarenal aorta, spinal cord were reperfused for 6h, 12h, 24h, 3d, 5d, and 7d separately. Enzyme-linked immunosorbent assay was used to detect vascular endothelial growth factor (VEGF) in serum. Immunohistochemistry was performed to detect protein expression of VEGF, VEGF receptor 1 (FLT-1) and VEGF receptor 2 (FLK-1). Gene expressions of VEGF and its receptors were evaluated using the quantitative reverse transcription polymerase chain reaction. RESULTS: Compared with the IRS group, gene and protein expressions of VEGF, FLT-1 and FLK-1 were significantly increased (P<0.05), so was the concentration of VEGF in plasma (P<0.05). FLK-1 was expressed on spinal cord neurons.
STUDY DESIGN: Experimental study. OBJECTIVES: To investigate whether Bosentan, an endothelin-A/-B dual receptor antagonist, could protect neurons after spinal cord ischemia reperfusion (SCIR) injury in rats and its underlying signaling pathway. SETTING: Department of Neurosurgery, the Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi Province, China. METHODS:Sprague-Dawley rats were randomly divided into two groups, saline group (IRS, n=48) and Bosentan group (IRB, 5 mg kg(-1), n=48). After ischemia for 1 h with occlusion of the infrarenal aorta, spinal cord were reperfused for 6h, 12h, 24h, 3d, 5d, and 7d separately. Enzyme-linked immunosorbent assay was used to detect vascular endothelial growth factor (VEGF) in serum. Immunohistochemistry was performed to detect protein expression of VEGF, VEGF receptor 1 (FLT-1) and VEGF receptor 2 (FLK-1). Gene expressions of VEGF and its receptors were evaluated using the quantitative reverse transcription polymerase chain reaction. RESULTS: Compared with the IRS group, gene and protein expressions of VEGF, FLT-1 and FLK-1 were significantly increased (P<0.05), so was the concentration of VEGF in plasma (P<0.05). FLK-1 was expressed on spinal cord neurons.
Authors: A Günther; B Enke; P Markart; P Hammerl; H Morr; J Behr; G Stähler; W Seeger; F Grimminger; I Leconte; S Roux; H-A Ghofrani Journal: Eur Respir J Date: 2007-01-10 Impact factor: 16.671
Authors: B Oosthuyse; L Moons; E Storkebaum; H Beck; D Nuyens; K Brusselmans; J Van Dorpe; P Hellings; M Gorselink; S Heymans; G Theilmeier; M Dewerchin; V Laudenbach; P Vermylen; H Raat; T Acker; V Vleminckx; L Van Den Bosch; N Cashman; H Fujisawa; M R Drost; R Sciot; F Bruyninckx; D J Hicklin; C Ince; P Gressens; F Lupu; K H Plate; W Robberecht; J M Herbert; D Collen; P Carmeliet Journal: Nat Genet Date: 2001-06 Impact factor: 38.330
Authors: Richard L Benton; Melissa A Maddie; Mark J Gruenthal; Theo Hagg; Scott R Whittemore Journal: Curr Neurovasc Res Date: 2009-05 Impact factor: 1.990